|
|
| Maladies Cardiovasculaires > Etude de marché sectorielle |
|
|
|
|
€ 525,00 |
Editeur
: |
Plimsoll Publishing Ltd |
Langue
: |
Anglais |
Date de publication : |
Février 2008 |
Taille du document : |
160 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
UK Market For Fitness Equipment
90 pages | Juillet 2002 |
This report will enable you to:Analyse the size of the UK market for fitness equipment, in value terms, 1997-2006Quantify the size of the UK market for commercial cardiovascular fitness equipment, 1 |
698,00 €
|
| |
| |
Nutraceuticals - Targeting Consumers Aged 35+
154 pages | Septembre 2000 |
Not only does the 35+ consumer group account for a significant and growing percentage of the total population; it is also at the greatest risk of major illnesses.
Despite advances in medicine |
955,00 €
|
| |
| |
US Cardiovascular Remedies 2004
14 pages | Décembre 2004 |
Snapdata's US Cardiovascular Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cardiovascular reme |
240,00 €
|
| |
| |
Latest Developments In Insulin Delivery Technology
10 pages | Novembre 2002 |
Insulin dependent diabetics used to depend on syringes as the mode of delivery of insulin.
Now, insulin pens, pumps and jet injectors are also being used.
But none of these existing technologies |
200,00 €
|
| |
| |
The US Healthcare Market into the 21st Century
130 pages | Mars 1999 |
Company specific analysis : The top 10 US based PoM companies are analysed and the growth strategies within these companies are identified.
Each company is assessed in a methodologically soun |
795,00 €
|
| |
| |
Reaching Cardiologists Online: Developing Marketing Strategies Consistent with Regional Demand
63 pages | Décembre 2004 |
IntroductionCardiologists rely on the Internet to access information and provide care for their patients.
An opportunity exists for pharmaceutical companies to provide cardiologists with many value |
3 040,00 €
|
| |
| |
The Emerging Drug Targets Outlook: An analysis of novel molecular targets to develop innovative new therapeutics
169 pages | Novembre 2005 |
Drug targets are generally proteins.
Nucleic acids are possible drug targets, and approaches such as RNA interference (RNAi) may indeed have advantages over proteins, but they have not so far been |
2 443,75 €
|
| |
| |
The World Hypertension Market 2005-2010
185 pages | Novembre 2005 |
The world hypertension market generated over $25 billion in 2004, with steady growth from the previous year.
In this report, visiongain forecasts that revenues in the world hypertension market will |
2 663,00 €
|
| |
| |
US Cholesterol-Reducing Statins 2004
12 pages | Décembre 2004 |
Snapdata's US Cholesterol-Reducing Statins 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cholesterol-re |
240,00 €
|
| |
| |
The Cardiovascular Outlook 2000
161 pages | Septembre 2000 |
In 1999, cardiovascular drugs represented the largest single segment of the global pharmaceutical industry by value.
Estimated sales of $69.6bn represented growth of 8.2% over 1998 levels.
|
955,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
The Plimsoll Portfolio Analysis - Fitness Equipment is a comprehensive evaluation of the UK market. The revised and updated 2008 edition analyses the financial performance of the companies important to the success of your business. Using the most up to date information available, the analysis is ideal both as a tool to benchmark your own company's results and to study the market in more depth. Aimed at the busy manager, the Plimsoll Portfolio Analysis is both quick and easy to use thanks to the unique visual layout. The Analysis lays bare the performance of each company highlighting their strengths and weaknesses. Do you know which companies are best to do business with? Do you know which companies are selling at a loss and whose profit margins are plummeting? Find out the answers to all these questions and more with the newly published Plimsoll Portfolio Analysis.
The report is divided into two colour-coded sections for your ease of use, Sector Analysis and Individual Company Analysis. Sector Analysis: Sales growth, market share and profitability are all analysed over a 10 year period giving you the fulllest picture possible of the health of the market. Companies are ranked on these categories so you can see which companies are outshining the rest. Use the industry average tables to benchmark your own company's performance- how do you compare to the rest of the industry? Industry Analysis: Each company receives a full page of analysis, evaluating their financial performance over the last five years so you get a full picture of the long term prospects of each company. Each company page of analysis is also packed with the following information: Full business name and address, Names and ages of directors, contact details and website address, seven unique 'Plimsoll' charts showing at a glance the performance of each company, averages for the industry are also shown indicating the bare minimum each company should be looking to achieve, and five years of the latest accounts available, New! Written summary on each company highlighting their key strengths and weaknesses.
The Analysis evaluates the performance of 77 companies.
|
|
|
PPLSEN
|
|
|
|
|
